Publication Details

Pubmed11245482
Title: Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Year: 2001
First Author: Bonvini
Experimental setup: affinity chromatography technology (Biogrid)
in vitro (Hprd)
in vivo (Hprd)
Throughput: Low Throughput (Biogrid)

Interactions

3 interactions
InteractorPartnerSourcesLink
CTNB1_HUMANCADH1_HUMANBioGRIDdetails
ERBB2_HUMANCTNB1_HUMANBioGRID, HPRDdetails
PTPRF_HUMANCTNB1_HUMANBioGRID, HPRDdetails